More or Less is produced in partnership with the Open University. Presenter: Tim Harford Reporter: Lizzy McNeill Producer: ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options ...

The advice to “eat less, move more” isn’t just outdated, it’s harmful. Obesity is a chronic condition shaped by biology, ...

ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care. As the sun rises over San Francisco, ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

Maternal obesity doesn't just affect the health of a pregnant woman. It can also have effects on her child, increasing their ...